First Manhattan group reports 9.6% stake in PAVmed (PAVM)

Rhea-AI Filing Summary

PAVmed Inc. ownership disclosure: First Manhattan Co. LLC, FMC Group Holdings LP and First Manhattan Management LLC report beneficial ownership of 639,191 shares of Common Stock, representing 9.6% of the class as of 03/31/2026. The cover page shows sole voting power 638,720 and shared voting power 471 for each filer.

Insights

Governance Analyst

Institutional holder reports a 9.6% stake in PAVmed.

The filing lists a combined beneficial position of 639,191 shares with sole voting power of 638,720 shares and shared voting power of 471 shares as shown on the cover page dated 03/31/2026. This level of ownership qualifies the filers as a notable holder under reporting rules.

Future disclosures may show changes; any activist intent or plans to trade are not stated in the excerpt.

Investor Relations Advisor

Three related entities report joint beneficial ownership and voting control figures.

The filing attributes identical voting and dispositive figures to each filer and lists their principal business address at 399 Park Avenue, New York. The signature block is dated 05/14/2026.

Share counts and the 9.6% stake are factual disclosures; the filing does not state any proposed transactions or changes to governance.

Key Figures

Total beneficially owned: 639,191 shares Sole voting power: 638,720 shares Shared voting power: 471 shares +1 more

4 metrics

Total beneficially owned 639,191 shares as of 03/31/2026

Sole voting power 638,720 shares cover page listed for each filer

Shared voting power 471 shares cover page listed for each filer

Percent of class 9.6% as of 03/31/2026

Key Terms

Schedule 13G, Beneficial ownership, Sole dispositive power

3 terms

Schedule 13G regulatory

"Item 2. | (a) | Name of person filing: First Manhattan Co. LLC"

A Schedule 13G is a formal document that investors file with the government when they acquire a large ownership stake in a company, usually for investment purposes rather than control. It helps keep the public informed about who owns significant parts of a company's shares, which can influence how the company is managed and how investors make decisions. Filing this schedule is important for transparency and understanding the ownership landscape of publicly traded companies.

Beneficial ownership financial

"Item 4. | Ownership (a) | Amount beneficially owned"

Beneficial ownership means the person or entity that actually enjoys the benefits of owning shares or other assets — such as receiving dividends, voting rights, or price gains — even if the legal title is held in another name. For investors it matters because knowing who truly controls and profits from a company reveals who can influence decisions, exposes potential conflicts of interest or hidden concentration of power, and affects transparency and risk in the stock.

Sole dispositive power regulatory

"7 | Sole Dispositive Power 638,720.00"

Sole dispositive power is the exclusive legal authority to decide what happens to a security — for example, whether to sell, transfer, or retain shares — without needing anyone else’s permission. Investors care because it signals who truly controls the economic outcome of an investment: like holding the only key to a safe, the holder can realize gains or losses and may trigger regulatory reporting, insider rules, or influence over corporate ownership.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

SCHEDULE 13G

UNDER THE SECURITIES EXCHANGE ACT OF 1934

PAVmed Inc.

(Name of Issuer)

Common Stock, Par Value $0.001 Per Share

(Title of Class of Securities)

70387R403

(CUSIP Number)

03/31/2026

(Date of Event Which Requires Filing of this Statement)

Check the appropriate box to designate the rule pursuant to which this Schedule is filed:

Rule 13d-1(b)

Rule 13d-1(c)

Rule 13d-1(d)

schemaVersion:

SCHEDULE 13G

CUSIP Number(s): 70387R403

1

Names of Reporting Persons

FIRST MANHATTAN CO. LLC.

2

Check the appropriate box if a member of a Group (see instructions)

(a)
(b)

3

Sec Use Only

4

Citizenship or Place of Organization

DELAWARE

Number of Shares Beneficially Owned by Each Reporting Person With:

5	Sole Voting Power 638,720.00
6	Shared Voting Power 471.00
7	Sole Dispositive Power 638,720.00
8	Shared Dispositive Power 471.00

9

Aggregate Amount Beneficially Owned by Each Reporting Person

639,191.00

10

Check box if the aggregate amount in row (9) excludes certain shares (See Instructions)

11

Percent of class represented by amount in row (9)

9.6 %

12

Type of Reporting Person (See Instructions)

IA

SCHEDULE 13G

CUSIP Number(s): 70387R403

1

Names of Reporting Persons

FMC Group Holdings LP

2

Check the appropriate box if a member of a Group (see instructions)

(a)
(b)

3

Sec Use Only

4

Citizenship or Place of Organization

DELAWARE

Number of Shares Beneficially Owned by Each Reporting Person With:

5	Sole Voting Power 638,720.00
6	Shared Voting Power 471.00
7	Sole Dispositive Power 638,720.00
8	Shared Dispositive Power 471.00

9

Aggregate Amount Beneficially Owned by Each Reporting Person

639,191.00

10

Check box if the aggregate amount in row (9) excludes certain shares (See Instructions)

11

Percent of class represented by amount in row (9)

9.6 %

12

Type of Reporting Person (See Instructions)

HC, PN

SCHEDULE 13G

CUSIP Number(s): 70387R403

1

Names of Reporting Persons

First Manhattan Management LLC

2

Check the appropriate box if a member of a Group (see instructions)

(a)
(b)

3

Sec Use Only

4

Citizenship or Place of Organization

DELAWARE

Number of Shares Beneficially Owned by Each Reporting Person With:

5	Sole Voting Power 638,720.00
6	Shared Voting Power 471.00
7	Sole Dispositive Power 638,720.00
8	Shared Dispositive Power 471.00

9

Aggregate Amount Beneficially Owned by Each Reporting Person

639,191.00

10

Check box if the aggregate amount in row (9) excludes certain shares (See Instructions)

11

Percent of class represented by amount in row (9)

9.6 %

12

Type of Reporting Person (See Instructions)

HC

SCHEDULE 13G

Item 1.
(a)	Name of issuer: PAVmed Inc.
(b)	Address of issuer's principal executive offices: 360 Madison Avenue, 25th Floor, New York, NEW YORK, 10017.
Item 2.
(a)	Name of person filing: First Manhattan Co. LLC FMC Group Holdings LP First Manhattan Management LLC Each a "Filer"
(b)	Address or principal business office or, if none, residence: The address of each Filer is 399 Park Avenue, 28th Floor, New York, NY 10022.
(c)	Citizenship: The citizenship for each Filer is the following: First Manhattan Co. LLC - Delaware FMC Group Holdings LP - Delaware First Manhattan Management LLC - Delaware
(d)	Title of class of securities: Common Stock, Par Value $0.001 Per Share
(e)	CUSIP Number(s): 70387R403
Item 3.	If this statement is filed pursuant to §§ 240.13d-1(b) or 240.13d-2(b) or (c), check whether the person filing is a:
(a)	Broker or dealer registered under section 15 of the Act (15 U.S.C. 78o);
(b)	Bank as defined in section 3(a)(6) of the Act (15 U.S.C. 78c);
(c)	Insurance company as defined in section 3(a)(19) of the Act (15 U.S.C. 78c);
(d)	Investment company registered under section 8 of the Investment Company Act of 1940 (15 U.S.C. 80a-8);
(e)	An investment adviser in accordance with § 240.13d-1(b)(1)(ii)(E);
(f)	An employee benefit plan or endowment fund in accordance with § 240.13d-1(b)(1)(ii)(F);
(g)	A parent holding company or control person in accordance with § 240.13d-1(b)(1)(ii)(G);
(h)	A savings associations as defined in Section 3(b) of the Federal Deposit Insurance Act (12 U.S.C. 1813);
(i)	A church plan that is excluded from the definition of an investment company under section 3(c)(14) of the Investment Company Act of 1940 (15 U.S.C. 80a-3);
(j)	A non-U.S. institution in accordance with § 240.13d-1(b)(1)(ii)(J). If filing as a non-U.S. institution in accordance with § 240.13d-1(b)(1)(ii)(J), please specify the type of institution:
(k)	Group, in accordance with Rule 240.13d-1(b)(1)(ii)(K).
Item 4.	Ownership
(a)	Amount beneficially owned: See Item 9 of the cover page for each Filer.
(b)	Percent of class: See Item 11 of the cover page for each Filer.
(c)	Number of shares as to which the person has:
	(i) Sole power to vote or to direct the vote: See Item 5 of the cover page for each Filer.
	(ii) Shared power to vote or to direct the vote: See Item 6 of the cover page for each Filer.
	(iii) Sole power to dispose or to direct the disposition of: See Item 7 of the cover page for each Filer.
	(iv) Shared power to dispose or to direct the disposition of: See Item 8 of the cover page for each Filer.
Item 5.	Ownership of 5 Percent or Less of a Class.
	Not Applicable
Item 6.	Ownership of more than 5 Percent on Behalf of Another Person.
	Not Applicable
Item 7.	Identification and Classification of the Subsidiary Which Acquired the Security Being Reported on by the Parent Holding Company or Control Person.
	Not Applicable
Item 8.	Identification and Classification of Members of the Group.
	Not Applicable
Item 9.	Notice of Dissolution of Group.
	Not Applicable

Item 10.

Certifications:

By signing below I certify that, to the best of my knowledge and belief, the securities referred to above were acquired and are held in the ordinary course of business and were not acquired and are not held for the purpose of or with the effect of changing or influencing the control of the issuer of the securities and were not acquired and are not held in connection with or as a participant in any transaction having that purpose or effect, other than activities solely in connection with a nomination under § 240.14a-11.

SIGNATURE

After reasonable inquiry and to the best of my knowledge and belief, I certify that the information set forth in this statement is true, complete and correct.

FIRST MANHATTAN CO. LLC.

Signature:	Jeremy Covino
Name/Title:	Chief Compliance Officer
Date:	05/14/2026

FMC Group Holdings LP

Signature:	Andrew Aspen
Name/Title:	Authorized Signatory
Date:	05/14/2026

First Manhattan Management LLC

Signature:	Andrew Aspen
Name/Title:	Authorized Signatory
Date:	05/14/2026

FAQ

What stake does First Manhattan report in PAVM?

They report beneficial ownership of 639,191 shares, representing 9.6% of PAVmed's common stock as of 03/31/2026. The cover page shows sole voting power 638,720 and shared voting power 471 for each filer.

Which entities filed the Schedule 13G for PAVM?

The filing names First Manhattan Co. LLC, FMC Group Holdings LP, and First Manhattan Management LLC with addresses at 399 Park Avenue, New York, NY. Each filer is organized in Delaware per the cover page.

What voting and dispositive powers are reported in the filing?

Each filer reports sole voting power of 638,720 shares, shared voting power of 471 shares, sole dispositive power of 638,720 shares, and shared dispositive power of 471 shares, as shown on the cover page.

When was the Schedule 13G signed for PAVM?

The signatures on the filing are dated 05/14/2026, and the cover page lists an ownership date of 03/31/2026. The filing is signed by Jeremy Covino and Andrew Aspen.